Anticoagulation Therapy by Age and Embolic Risk for Nonvalvular Atrial Fibrillation in Mexico, an Upper-Middle-Income Country: The CARMEN-AF Registry.

ABSTRACT:

Background

Documenting the patterns of oral anticoagulation therapy (OAT) is essential to prevent thromboembolic complications of nonvalvular atrial fibrillation (NVAF).

Objective

To report the patterns of OAT according to age and thromboembolic risk in patients included in CARMEN-AF, a nationwide registry of NVAF in Mexico, an upper middle-income country.

Material and methods

There were 1,423 consecutive patients ≥18 years old and with at least one thromboembolic risk factor enrolled in the CARMEN-AF Registry at their regular clinical visit during a three-year period. They were analyzed according to 1) age, 2) AF type, and 3) CHA₂DS₂-VASc score.

Results

Overall, 16.4% of patients did not receive antithrombotic treatment, 19.4% received an

SUBMITTER: Marquez MF 

PROVIDER: S-EPMC7218765 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature